e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Biomarkers in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis
L. Guillot, G. Thouvenin, F. Flamein, C. Caillaud, K. Chadelat, C. Charlier, J. Beucher, H. Corvol, A. Clement, R. Epaud (Paris, France)
Source:
Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Session:
Biomarkers in diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
5668
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Guillot, G. Thouvenin, F. Flamein, C. Caillaud, K. Chadelat, C. Charlier, J. Beucher, H. Corvol, A. Clement, R. Epaud (Paris, France). Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 5668
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
Source: Eur Respir J 2001; 17: 716-722
Year: 2001
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007
Elastase and α1-proteinase inhibitor in bronchoalveolar lavage fluid of children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Activity of proteinase-inhibitor enzymes and secretory sIg A of patients with chronic obctructive pulmonary disease in bronchoalveolar lavage fluid
Source: Annual Congress 2006 - Implications of progressive airway obstruction
Year: 2006
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002
SP-A and blastase in BAL during mechanicalventiration
Source: Eur Respir J 2004; 24: Suppl. 48, 204s
Year: 2004
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006
Altered expression of bronchoalveolar lavage fluid proteins in sarcoidosis: A proteomics approach
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept